A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma - Concepedia

Concepedia

Publication | Open Access

A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma

DOI Full Paper Access

42

Citations

47

References

2010

Year

Hui Huang, Michael E. Menefee, Maureen Edgerly, Sen Hong Zhuang, Herb Kotz, Marianne S. Poruchynsky, Lyn M. Huff, Susan E. Bates, Tito Fojo

Clinical Cancer Research

Abstract

Ixabepilone can cause tumor regression in some patients with metastatic renal cell carcinoma and could be considered in combination regimens with other therapies.

References

	Year	Citations

Page 1